Open AccessJournal Article
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Shaul G. Massry,Jack W. Coburn,Glenn M. Chertow,Keith A. Hruska,Craig B. Langman,Hartmut H. Malluche,Kevin J. Martin,Linda McCann,James T. McCarthy,Sharon M. Moe,Isidro B. Salusky,Donald J. Sherrand,Miroslaw Smogorzewski,Kline Bolton,Charles Turkelson,Karyn A. Tappe,Stephen Tregear,James Reston,Wendy Bruening,Mark Monteforte,Janice Kaczmarek,Vivian Coates,George R. Bailie,Bryan N. Becker,Gavin J. Becker,Jerrilynn D. Burrowes,Fernando Carrera,David N. Churchill,Allan J. Collins,Peter W. Crooks,Dick DeZeeuw,Thomas A. Golper,Frank A. Gotch,Antonio M. Gotto,Roger Greenwood,Joel W. Greer,Richard H. Grimm,William E. Haley,Ronald J. Hogg,Alan R. Hull,Lawrence G. Hunsicker,Cynda Ann Johnson,Michael J. Klag,Saulo Klahr,Norbert Lameire,Francesco Locatelli,Sally McCulloch,Maureen Michael,Joseph V. Nally,John M. Newmann,Allen R. Nissenson,Keith C. Norris,Gregorio T. Obrador,William F. Owen,Thakor G. Patel,Glenda Payne,Claudio Ronco,Rosa A. Rivera-Mizzoni,Anton C. Schoolwerth,Robert A. Star,Michael W. Steffes,Theodore I. Steinman,John Pierre Wauters,Nanette K. Wenger,Josephine P. Briggs,Thomas H. Hostetter,Garabed Eknoyan,Aderra Levin,Nathan W. Levin,Sharon Andreoli,Sally Burrows-Hudson,Derrick Latos,Donna Mapes,Edith Oberley,Brian J.G. Pereira,Nadine Ferguson,Donna Fingerhut,Anthony Gucciardo,Margaret Klette,Doreen Mallard,Kerry Willis +80 more
Reads0
Chats0
About:
This article is published in American Journal of Kidney Diseases.The article was published on 2003-10-01 and is currently open access. It has received 2609 citations till now. The article focuses on the topics: Chronic kidney disease-mineral and bone disorder & Kidney disease.read more
Citations
More filters
Journal ArticleDOI
Non-calcium-containing phosphate binders: comparing efficacy, safety, and other clinical effects.
João M. Frazão,Teresa Adragão +1 more
TL;DR: The evidence of efficacy and safety for newer calcium-free phosphate binders in CKD-MBD management is summarized, with sevelamer having a positive effect on bone disease, vascular calcification, and patient-level outcomes in dialysis patients in several trials.
Journal ArticleDOI
Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study
Hiroo Kawarazaki,Yugo Shibagaki,Seiji Fukumoto,Ryo Kido,Katsuyuki Ando,Ichiro Nakajima,Shohei Fuchinoue,Toshiro Fujita,Masafumi Fukagawa,Satoshi Teraoka +9 more
TL;DR: The need for testing of other interventions used for treatment of hyperparathyroidism which may help to offer better management of MBD after kidney transplantation is suggested.
Journal ArticleDOI
Post-Parathyroidectomy Parathyroid Hormone Levels: The Impact on Patient Survival – A Single-Centre Study in a Stage 5 Chronic Kidney Disease Population
TL;DR: An association between the lowest quartile of iPTH recovery in the 5 years following PTX and poorer patient survival was found and should be tested in larger datasets.
Journal ArticleDOI
Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study
Jennifer Ennis,Daniel L. Gillen,Arthur H. Rubenstein,Elaine M. Worcester,Mark E. Brecher,John R. Asplin,Fredric L. Coe +6 more
TL;DR: Physicians who used the CDSS ordered all CKD-relevant testing more in accord with guidelines than those who did not use the system, which may improve physician adherence to guidelines with respect to timely monitoring of CKD.
Journal ArticleDOI
Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5.
TL;DR: No harmful effects of short-term treatment with high-dose ergocalciferol were observed on markers of mineral homeostasis and FGF23 in CKD patients stage 4–5, and no changes were seen in the circulating vitamin D concentrations in the control group.
References
More filters
Journal ArticleDOI
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Geoffrey A. Block,Kevin J. Martin,Angel L.M. de Francisco,Stewart A. Turner,Morrell M. Avram,Michael Suranyi,Gavril Hercz,John Cunningham,Ali K. Abu-Alfa,Piergiorgio Messa,Daniel W. Coyne,Francesco Locatelli,Raphael M. Cohen,Pieter Evenepoel,Sharon M. Moe,Albert Fournier,Johann Braun,Laura C. McCary,Valter J. Zani,Kurt Olson,Tilman B. Drüeke,William G. Goodman +21 more
TL;DR: Cinacalcet lowers parathyroid hormone levels and improves calcium-phosphorus homeostasis in patients receiving hemodialysis who have uncontrolled secondary hyperparathyroidism.